Gene expression profiling categorizes DLBCL based on cell-of-origin, where NFκB activation is the key feature of the less curable activated B-cell-like (ABC)-DLBCL [14]. This evidence concerns the gene NFKB1 and diffuse large B-cell lymphoma.